Fractional excretion of sodium is the amount of salt (sodium) that leaves the body through urine compared to the amount filtered and reabsorbed by the kidney.
Fractional excretion of sodium (FENa) is not a test. Instead it is a calculation based on the concentrations of sodium and creatinine in the blood and urine. Urine and blood chemistry tests are needed to perform this calculation.
How the Test is Performed
How to Prepare for the Test
Eat your normal foods with a normal amount of salt, unless otherwise instructed by your health care provider.
If needed, you may be told to temporarily stop medicines that interfere with test results. For example, some diuretic medicines (water pills) can affect test results.
How the Test will Feel
When the needle is inserted to draw blood, some people feel moderate pain. Others feel only a prick or stinging. Afterward, there may be some throbbing or slight bruising. This soon goes away.
Why the Test is Performed
The test is usually done for people who are very ill with acute kidney disease. The test helps determine if the drop in urine production is due to reduced blood flow to the kidney or to kidney damage itself.
What Abnormal Results Mean
A meaningful interpretation of the test can be made only when your urine volume has dropped to less than 500 mL/day.
FENa higher than 1% suggests damage to the kidney itself.
Veins and arteries vary in size from one person to another and from one side of the body to the other. Obtaining a blood sample from some people may be more difficult than from others.
Other risks associated with having blood drawn are slight but may include:
- Excessive bleeding
- Fainting or feeling lightheaded
- Hematoma (blood accumulating under the skin)
- Infection (a slight risk any time the skin is broken)
- Multiple punctures to locate veins
There are no risks with the urine sample.
FE sodium; FENa
Chernecky CC, Berger BJ. Excretion fraction of filtered sodium-blood and urine. In: Chernecky CC, Berger BJ, eds. Laboratory Tests and Diagnostic Procedures. 6th ed. St Louis, MO: Elsevier; 2013:497-498.
Parikh CR, Koyner JL. Biomarkers in acute and chronic kidney diseases. In: Skorecki K, Chertow GM, Marsden PA, Taal MW, Yu ASL, eds. Brenner and Rector's The Kidney. 10th ed. Philadelphia, PA: Elsevier; 2016:chap 30.
Polonsky TS, Bakris GL. Alterations in kidney function associated with heart failure. In: Mann DL, Felker GM, eds. Heart Failure: A Companion to Braunwald's Heart Disease. 3rd ed. Philadelphia, PA: Elsevier; 2016:chap 14.
Review Date 10/26/2017
Updated by: Walead Latif, MD, Nephrologist and Clinical Associate Professor, Rutgers Medical School, Newark, NJ. Review provided by VeriMed Healthcare Network. Also reviewed by David Zieve, MD, MHA, Medical Director, Brenda Conaway, Editorial Director, and the A.D.A.M. Editorial team.